Login to Your Account



Other News To Note


Wednesday, December 7, 2011
• Numerate Inc., of San Bruno, Calif., entered a research collaboration with Boehringer Ingelheim (Canada) Ltd., of Burlington, Ontario. The collaboration will use Numerate's in silico drug design technology to generate small-molecule drug leads for an undisclosed infectious disease target.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription